In a median follow-up of 56 months considering patients with CKD stages 3–4, Baek SH et al. demonstrated that each 10 μg/mL increase in serum renalase was associated with significantly greater hazards of all-cause mortality and adverse renal outcomes [46]. This evidence concerns the gene RNLS and chronic kidney disease.